Application Nr Approved Date Route Status External Links
ANDA076159 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Glipizide Extended-Release Tablets Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. Glipizide Extended-Release Tablets Are A Sulfonylurea Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. Limitations Of Use: Not For Treatment Of Type 1 Diabetes Or Diabetic Ketoacidosis. 1.1 Limitations Of Use Glipizide Extended-Release Tablets Are Not Recommended For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Glipizide GLIPIZIDE ZINC537795

Comments